CIBC Asset Management
AVNS icon

CIBC Asset Management’s Avanos Medical AVNS Stock Holding History

CIBC Asset Management’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-6,756
Closed -$226K – 1290
2022
Q1 		$226K Hold
6,756
– – ﹤0.01% 1272
2021
Q4 		$234K Buy
+6,756
New +$218K ﹤0.01% 1268

Other funds holding AVNS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RC
RGM Capital Naples, Florida $2.06B AUM 8.49% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $532M AUM 29.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
WHG
Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

CIBC Asset Management's AVNS Position: Q2 2022 in Review

CIBC Asset Management sold out of Avanos Medical (AVNS) in Q2 2022, closing a stake of 6,756 shares — an estimated $226K sold.

CIBC Asset Management first reported a position in AVNS in Q4 2021 and held it in 2 quarters. The position peaked at $234K in Q4 2021. 287 funds tracked by Wall St. Rank hold AVNS as of Q2 2022.

  • CIBC Asset Management reported no remaining Avanos Medical position as of Q2 2022 after selling out during the quarter.
  • CIBC Asset Management sold 6,756 Avanos Medical shares in Q2 2022, an estimated $226K.
  • CIBC Asset Management first reported a position in Avanos Medical in Q4 2021 and held it in 2 quarters.
  • CIBC Asset Management's Avanos Medical position peaked at $234K in Q4 2021.
  • 287 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2022.

Based on CIBC Asset Management's 13F filing for Q2 2022, filed 9 Aug 2022.